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tant problem.1 Neurologic injury ranges from neuropsy-
chologic impairment, which is very common but diffi-
cult to detect, to stroke, which is infrequent but devas-
tating. Several investigators have demonstrated that
neuropsychologic impairment occurs in 50% to 70% of
patients undergoing CABG within 1 week after the
operation,2,3 with 30% to 40% of patients having long-
term cognitive deficits.4,5
The introduction of transcranial Doppler ultrasonog-
raphy in the cardiac operating room has revealed that
cerebral microemboli occur in virtually all patients dur-
ing cardiopulmonary bypass (CPB),6,7 a finding that has
been verified by retinal fluorescein angiography8 and
postmortem histologic analysis.9 These emboli are
thought to be the principal reason for the development
of postoperative neuropsychologic impairment.10,11
D espite continuous improvements in cardiac morbid-ity and mortality after coronary bypass surgery
(CABG), neurologic complications remain an impor-
Background: Cerebral emboli occur during cardiopulmonary bypass and
are a principal cause of postoperative neurologic dysfunction. We
hypothesized that arterial cannulation of the distal aortic arch, with
placement of the cannula tip beyond the left subclavian artery, will
result in fewer cerebral microemboli than conventional cannulation of
the ascending aorta. Methods: Patients undergoing coronary bypass
surgery with a single crossclamp technique were randomized to receive
cannulation of the distal aortic arch (n = 17) or standard cannulation of
the ascending aorta (control group, n = 17). Trendelenburg positioning
was used whenever possible. Cerebral emboli were quantified by con-
tinuous transcranial Doppler monitoring of the middle cerebral artery.
Results: Baseline demographics were similar for the 2 groups of patients,
including cardiopulmonary bypass and crossclamp times. Cerebral
microemboli were detected during cardiopulmonary bypass in all
patients, with a range of 17 to 627 emboli. The total number of detected
emboli was lower in the arch cannulation group (152 ± 33, mean ± stan-
dard error of the mean) than in the conventional cannulation group (249
± 35, P = .04). Embolization rates were lower in distal arch patients than
in control patients during cardiopulmonary bypass (2.0 ± 0.3 vs 4.2 ± 0.9
per minute, respectively, P = .03). Reduction in cerebral emboli by dis-
tal arch cannulation was most pronounced during perfusionist interven-
tions. Conclusions: Cannulation of the distal aortic arch results in less
cerebral microembolism than conventional cannulation of the ascending
aorta. Provided it is performed safely, distal arch cannulation may be an
important surgical option for patients with severe atherosclerosis of the
ascending aorta. (J Thorac Cardiovasc Surg 1999;118:740-5)
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However, few published clinical trials have investigat-
ed methods of reducing cerebral embolization during
CPB.12-15
We have previously demonstrated that the majority of
cerebral emboli during CPB consist of air.16 Since air
bubbles ascend in blood, we hypothesized that CPB
arterial inflow distal to the carotid arteries, combined
with Trendelenburg positioning, will result in delivery
of an increased proportion of emboli to the distal circu-
lation and decreased embolization to the cerebral circu-
lation. We therefore conducted a randomized, con-
trolled clinical trial comparing rates of cerebral
embolism after cannulation of the distal aortic arch,
with positioning of the cannula tip beyond the left sub-
clavian artery, to embolic rates after conventional can-
nulation of the ascending aorta.
Methods
Patient population. From November 1997 to August
1998, 40 patients undergoing isolated CABG by one surgeon
(C.M.F.) consented to participate in this trial. A total of 198
patients underwent CABG by C.M.F. over this same time
period. The predominant determinant of whether or not
patients were approached to participate was the availability of
the transcranial Doppler ultrasonograph and appropriate per-
sonnel. Patients were excluded if they had a history of carotid
stenosis or carotid bruit (n = 18), if they had previous CABG
(n = 20), or if concomitant surgical procedures were planned
(n = 51). Patients who consented to participate in the trial
were excluded in the operating room if they had evidence of
atherosclerosis of the ascending or transverse aorta as deter-
mined by digital palpation (n = 2). Four patients who con-
sented were also excluded because of an inability to obtain an
adequate transcranial Doppler signal of the middle cerebral
artery. After these exclusions, 34 randomized patients formed
the focus of the remainder of this article. Patients were ran-
domized within the operating room, via an opaque sealed
envelope, to one of two aortic cannulation techniques: group
I, cannulation of the distal aortic arch (n = 17), and group II,
standard cannulation of the ascending aorta (control patients,
n = 17). On the basis of previous data,16 we determined that a
sample size of 17 patients per group would give us an 80%
chance of detecting a 25% relative risk reduction in our pri-
mary outcome, mean cerebral emboli per minute, with a cor-
responding a -level of .05.
The experimental protocol was approved by the Human
Experimentation Committee of The Toronto Hospital and all
participating patients gave informed written consent.
Operative management. Anesthetic management consist-
ed of induction with midazolam, fentanyl, and sodium
thiopental, followed by maintenance with isoflurane and
propofol. All patients received a Swan-Ganz catheter (Baxter
Healthcare Corp, Edwards Division, Santa Ana, Calif) placed
through the right internal jugular vein.
Patients were randomized within the operating room to
conventional cannulation of the ascending aorta with a 24F
standard arterial cannula (model 6672, Sarns/3M Health
Care, Ann Arbor, Mich) or to cannulation of the distal aortic
arch with a 24F flexible aortic arch cannula (model 4335,
Sarns). The aortotomy was located just proximal to the
innominate artery in the conventional cannulation group and
on the inferolateral aspect of the arch, just proximal to the
origin of the left subclavian artery, in the arch cannulation
group. The aortic arch cannula was inserted approximately 8
cm and directed into the descending aorta, thus ensuring that
the tip was distal to the left subclavian artery. Both cannulas
had a single distal aperture for the exit of blood.
Trendelenburg positioning of the patient (approximately 20°)
was used whenever possible.
Myocardial protection consisted of intermittent cold ante-
grade blood cardioplegia. All patients received a left internal
thoracic artery graft to the left anterior descending coronary
artery, plus additional saphenous vein grafts as required. All
anastomoses were performed during a single period of aortic
crossclamping.
CPB was established with the appropriate randomized arte-
rial cannula and a single 2-stage right atrial cannula. The
CPB circuit consisted of a softshell venous reservoir, a hol-
low-fiber membrane oxygenator, and nonpulsatile roller
pumps. A 32-m m filter was used in the arterial perfusion line.
The hematocrit value was maintained between 20% and 25%
during CPB, pump flow rates between 2.0 and 2.5 L · min–1
·m–2, and mean arterial pressure between 50 and 70 mm Hg
by use of phenylephrine as required. Systemic body temper-
ature was allowed to drift to a minimum of 34°C, with active
rewarming to 37.5°C at the end of CPB.
Transcranial Doppler monitoring. A transcranial
Doppler ultrasonograph (MultiDop X4, DWL, Sipplingen,
Germany) was used to continuously monitor the middle cere-
bral artery during the operation. We attempted to monitor
both middle cerebral arteries in all patients but were unable to
obtain a satisfactory signal from 1 artery in 8 patients. The
Doppler sound was turned off during monitoring to keep the
operative team blinded to the number and timing of microem-
boli. A 2-MHz pulsed-wave transducer (diameter = 1.7 cm)
was used to simultaneously monitor 2 depths spaced 4.97 mm
apart. The mean (± standard deviation) insonation depths
were 48.9 ± 1.1 mm and 53.8 ± 1.1 mm. A 64-point fast
Fourier transform was used. In addition, a high-pass filter set
at 100 Hz and a low-pass filter at 80 kHz were used.
Detection and analysis of microemboli. We have previ-
ously described our method of microembolus detection.16 In
brief, automated software (TCD-8 for MultiDop · 4, version
8.00q) was used to discriminate between emboli and artifact
according to the bigate method.17 Simultaneous monitoring
of 2 different depths of the middle cerebral artery was used.
High-intensity signals were considered artifact if they
occurred in both depths simultaneously. They were consid-
ered emboli if they appeared sequentially in a manner that
was consistent with flow velocity and distance between the 2
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sample volumes. In addition, manual off-line analysis of all
high-intensity signals was performed by an observer blinded
to patient group assignment. A detection threshold of 12 dB
was used to improve reproducibility while maximizing sensi-
tivity, in accordance with recommendations of an interna-
tional consensus group.18
Cerebral embolization rates were calculated as the number
of emboli detected per minute. For those patients who had
both middle cerebral arteries monitored, we evaluated the
artery with the highest quality signal.
Statistical analysis. Data are expressed as mean ± standard
deviation for continuous variables and as percentages for cat-
egoric variables. Baseline patient demographics were com-
pared by means of the Student t test, c 2, or Fisher’s exact test
where appropriate. Embolic rates between the 2 treatment
groups were compared by means of the Student t test. The
effect of perfusionist interventions and treatment group, as
well as their interaction, were simultaneously assessed with a
2-way analysis of variance. Analysis of covariance was used to
assess for possible confounding variables. All analyses were
performed with SAS software (SAS Institute, Inc, Cary, NC).
Results
Baseline and intraoperative demographics for the 2
groups of patients are displayed in Table I. There were
no significant differences between the 2 groups for any
variable.
Postoperative outcomes for both groups of patients
are presented in Table II. There were no aortic dissec-
tions in either group. One patient in the distal arch can-
nulation group required re-exploration for bleeding.
The bleeding site was identified as a mediastinal vein;
the arch cannulation site was hemostatic. Postoperative
low cardiac output syndrome occurred in a patient who
underwent arch cannulation and had preoperative renal
failure and a left ventricular ejection fraction of 20%.
This patient subsequently developed pneumonia and
sepsis but ultimately recovered and was discharged
home 2 months after CABG. There were no deaths in
either group.
Cerebral microemboli were detected in all patients,
with a range of 17 to 509 in the distal arch group and a
range of 84 to 627 in the conventional cannulation
group. The total number of detected emboli was lower
in the arch cannulation group (152 ± 33, mean ± stan-
dard error of the mean) than in the conventional cannu-
lation group (249 ± 35, P = .04). Fig 1 reveals mean
cerebral embolization rates during CPB for the 2
groups of patients. Distal aortic arch cannulation
resulted in significantly fewer cerebral microemboli
during CPB (2.0 ± 0.3 emboli per minute) than con-
ventional cannulation of the ascending aorta (4.2 ± 0.9,
P = .03). Similarly, cerebral embolization rates during
the entire operative procedure were significantly lower
with arch cannulation (1.4 ± 0.3 emboli per minute)
than in control patients (2.4 ± 0.5, P = .04).
Fig 2 displays the mean embolic rates for both groups
of patients during 3 time periods. Perfusionist events
Table I. Preoperative and intraoperative demograph-
ics for the 2 aortic cannulation groups*
Group I Group II 
(distal arch, (control,
Variable n = 17) n = 17) P value
Preoperative
Female sex 4 (24%) 2 (12%) .7
Age (y) 59 ± 10 63 ± 8 .3
BSA (m2) 1.88 ± 0.19 1.93 ± 0.29 .6
Diabetes mellitus 4 (24%) 5 (29%) .7
Hypertension 12 (71%) 8 (47%) .16
Hypercholesterolemia 14 (82%) 12 (71%) .4
Renal insufficiency 3 (18%) 4 (24%) .8
or failure
LVEF <40% 7 (41%) 4 (24%) .5
CCS angina class 3 or 4 14 (82%) 12 (71%) .4
NYHA class III or IV 4 (24%) 6 (35%) .7
Intraoperative
No. of CABGs 3.5 ± 0.9 3.7 ± 0.7 .4
CPB time (min) 83 ± 25 86 ± 13 .7
Crossclamp time (min) 63 ± 16 65 ± 9 .8
BSA, Body surface area; LV, left ventricle; CCS, Canadian Cardiovascular
Society; NYHA, New York Heart Association; CABG, coronary artery bypass
grafting; CPB, cardiopulmonary bypass.
*Values are expressed as number of patients, with percentage in parentheses,
for categoric variables and mean ± standard deviation for continuous variables. 
Table II. Postoperative outcomes for the 2 aortic can-
nulation groups*
Group I Group II 
(distal arch, (control,
Outcome n = 17) n = 17)
Chest tube blood loss (mL/24 h) 524 ± 208 678 ± 279
Re-exploration for bleeding 1 (6%) 0 (0%)
Myocardial infarction 0 (0%) 0 (0%)
Low cardiac output syndrome 1 (6%) 0 (0%)
Arrhythmias
Atrial fibrillation 3 (18%) 6 (35%)
Other 0 (0%) 0 (0%)
Stroke 0 (0%) 0 (0%)
Other
Pneumonia, sepsis 1 (6%) 0 (0%)
Intensive care unit length of stay (h) 27 ± 15 31 ± 18
Hospital length of stay (days) 6.6 ± 1.7† 6.2 ± 1.9
Death 0 (0%) 0 (0%)
There was no significant difference between groups for any outcome.
*Values are expressed as number of patients, with percentages in parentheses, for
categoric variables and mean ± standard deviation for continuous variables.
†Excluding 1 patient with a postoperative length of stay of 64 days (see text).
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were defined as the 2-minute time period after injection
of drugs or blood samples into the venous reservoir by
the perfusionist, an event that we have previously
demonstrated to be the predominant cause of cerebral
emboli during CPB.16 (Injections were made by means
of a manifold directly connected to the venous line, just
proximal to the venous reservoir.) Surgical events were
defined as the 2-minute time period after aortic cannu-
lation/decannulation, CPB start/end, crossclamp appli-
cation/removal, and start of cardiac ejection, events that
have previously been described as causes of cerebral
emboli.7,15,19 Baseline events were all time periods
excluding perfusionist or surgical events. As Fig 2
reveals, the reduction of cerebral embolization by dis-
tal arch cannulation was most pronounced during per-
fusionist interventions (P = .01).
Analysis of covariance failed to identify any con-
founding variables including individual perfusionist,
side of middle cerebral artery monitoring, and patient
demographics as listed in Table I.
Discussion
Neurologic morbidity after CABG has received
increasing attention in the literature.1 Stroke is the most
thoroughly studied complication but occurs in only a
small percentage of patients.20,21 Postoperative neu-
ropsychologic impairment, in contrast, is very com-
mon. This complication is important because approxi-
mately half of patients are aware of their cognitive
deficits22 and one third of patients display long-stand-
ing impairment.4,5
Cerebral microemboli have been established as the
principal cause of postoperative neuropsychologic
impairment.10,11 Several investigators have documented
that cerebral embolization occurs in virtually all
patients undergoing CPB and that a reduction in the
number of emboli is associated with less cognitive
impairment.8,11,13,23-25 Hammon and associates11
assessed neuropsychologic impairment in 395 patients
undergoing CABG and demonstrated that 100 or more
cerebral emboli, as quantified by transcranial Doppler
sonography, is an independent predictor of cognitive
dysfunction. Pugsley and coworkers23 found 43% of
patients with more than 1000 emboli had neuropsycho-
logic impairment 8 weeks after the operation, com-
pared with only 9% of patients with fewer than 200
emboli. Similarly, Blauth and associates8 used retinal
fluorescein angiography to demonstrate increased
emboli in patients with cognitive deficits compared
with those without deficits. Sylivris and coworkers24
recently demonstrated a lower mean embolic rate
(number of cerebral emboli per minute of CPB) in
patients with neuropsychologic impairment compared
with those without impairment.
The precise composition of cerebral microemboli
during CPB is not known.6 We16 have previously
demonstrated that the vast majority of emboli occur
immediately after the injection of drugs, as well as
small amounts of air contained within the syringe, into
the venous reservoir by the perfusionists. We recorded
cerebral embolic rates during CABG and found a 7-
fold increase in emboli detection after perfusionist
events when compared with other time periods. In
addition, we found that careful deairing of the syringe
before injection into the CPB circuit resulted in less
embolization. These findings would strongly suggest
that the majority of cerebral emboli during CPB consist
of microbubbles. Further evidence for this conclusion
can be found in a randomized trial by Padayachee and
associates.15 These investigators demonstrated that
bubble oxygenators result in significantly more cere-
bral emboli than membrane oxygenators. Because air
emboli would be expected to ascend in blood, we
hypothesized that cannulation of the distal aortic arch,
with placement of the cannula tip into the descending
aorta and Trendelenburg positioning, would result in
less cerebral embolization than conventional cannula-
tion of the ascending aorta.
The current study assessed 34 patients undergoing
CABG in a prospective, randomized trial. We found
significantly lower cerebral embolic rates in patients
randomized to distal arch cannulation, with the most
Fig 1. Comparison of cerebral embolization rates during CPB
(mean ± standard error of the mean) between aortic arch can-
nulation and conventional ascending aorta cannulation
groups. There were significantly fewer cerebral emboli per
minute in the distal arch group.
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pronounced effect during perfusionist interventions.
We believe this is an important finding because
microembolization is an important cause of postopera-
tive neuropsychologic impairment. Although the
majority of emboli in our study probably consisted of
microbubbles, which may be less detrimental than ath-
erosclerotic debris because of the ability of air to
resorb, we believe that any reduction in cerebral embol-
ic load is clinically significant.
The current study excluded patients with evidence of
aortic or carotid atherosclerosis to minimize possible
confounding factors. However, we believe that patients
with aortic atherosclerosis may also benefit from distal
arch cannulation. Although atherosclerosis of the aortic
arch is more common than atherosclerosis of the
ascending aorta, the disease process is often localized to
the superior portion of the arch.26 It is sometimes possi-
ble, therefore, to find a disease-free segment of the infe-
rior aortic arch in patients with diffuse atherosclerosis
of the ascending aorta. Indeed, our largest experience
for this particular cannulation technique is in this
patient population. Furthermore, use of a long, straight
arterial cannula, as used in the current study for arch
cannulation, is associated with lower peak aortic flow
velocities than conventional short, right-angled cannu-
las.27 A decrease in flow velocity, as well as positioning
of the cannula tip below the left subclavian artery, may
result in decreased embolization from an atherosclerot-
ic aortic wall (known as the “sandblast effect”). Distal
arch cannulation, therefore, may be the preferred tech-
nique for patients with aortic atherosclerosis.
The benefits of distal arch cannulation would be mit-
igated if any serious complications arose from this pro-
cedure. The small number of patients involved in this
study limits conclusions on the safety of this procedure.
However, we have previously performed distal arch
cannulation in well over 200 patients, predominantly
for diffuse atherosclerosis of the ascending aorta. There
have been no cases of aortic dissection in this group of
patients. In addition, there have been no re-explorations
for bleeding from the arch cannulation site. We there-
fore believe that distal aortic arch cannulation is a safe
and effective procedure.
Study limitations
One limitation of this study is that we did not per-
form neuropsychologic testing in the 2 groups of
patients. Because of the small number of patients
planned for this study, however, we thought that we
would not have the power to comment on neuropsy-
chologic outcomes. Approximately 200 patients per
group would be required to detect a 30% relative risk
reduction in cognitive impairment. In addition, we
thought there was significant evidence in the literature
supporting the role of microemboli in the etiology of
neuropsychologic impairment.
Another limitation of this study is that we did not use
epiaortic ultrasonography or transesophageal echocar-
diography in the assessment of atherosclerosis of the
aorta. The use of digital palpation alone may have
resulted in unequal distribution of patients with mild to
moderate aortic atherosclerosis to one of the random-
Fig 2. Cerebral embolization rates during perfusionist interventions, surgical interventions, and during baseline
(see text for definitions). The decrease in cerebral embolization by distal arch cannulation was most pronounced
during perfusionist interventions.
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ized groups. However, we have demonstrated that the
majority of cerebral emboli during CPB are associated
with perfusionist events and therefore probably consist
of air. This finding would suggest that the presence of
mild to moderate atherosclerosis would not significant-
ly affect our findings of decreased cerebral emboli with
arch cannulation.
Conclusions
Distal aortic arch cannulation results in less cerebral
microembolism than conventional cannulation of the
ascending aorta, particularly during perfusionist inter-
ventions. Provided it is performed safely, distal arch
cannulation may be an important surgical option in the
management of patients with severe atherosclerosis of
the ascending aorta.
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